Arrivo BioVentures
PrivateLast Round
Series B
Nov 29, 2023
Total Funding Raised
$45.25M
Company Overview
Arrivo BioVentures is a biopharmaceutical company that develops reformulated drugs aimed at enhancing patient care through the identification of biologics and small molecules, utilizing innovative regulatory strategies and efficient clinical programs to support biotech companies in meeting their drug demands.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arrivo BioVentures Comps
Public and private peers based on sector, stage, and business model.
Arrivo BioVentures Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 29, 2023 | ||||
| VC Round | May 25, 2016 |
Key People
Founding team and executive leadership
Arrivo BioVentures Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orlando Health Ventures | Series B |
| Solas BioVentures | VC Round, Series B |
| Rex Health Ventures | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 31% MoM.
Arrivo BioVentures Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arrivo BioVentures's valuation, stock price, and market status.
